+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Lacosamide"

Lacosamide Drugs Market - Global Forecast 2025-2030 - Product Thumbnail Image

Lacosamide Drugs Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 185 Pages
  • Global
From
Lacosamide Injection Market - Global Forecast to 2030 - Product Thumbnail Image

Lacosamide Injection Market - Global Forecast to 2030

  • Report
  • August 2025
  • 198 Pages
  • Global
From
From
Antiepileptic Drugs Market Report 2025 - Product Thumbnail Image

Antiepileptic Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Epilepsy - Pipeline Insight, 2025 - Product Thumbnail Image

Epilepsy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 280 Pages
  • Global
From
Refractory Status Epilepticus - Pipeline Insight, 2025 - Product Thumbnail Image

Refractory Status Epilepticus - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
From
  • 16 Results (Page 1 of 1)
Loading Indicator

Lacosamide is a medication used to treat epilepsy and other seizure disorders. It is classified as an antiepileptic drug (AED) and is used to treat partial-onset seizures in adults and adolescents over 12 years of age. Lacosamide is also used to treat generalized tonic-clonic seizures in adults and adolescents over 16 years of age. It works by increasing the amount of a neurotransmitter called GABA in the brain, which helps to reduce the number of seizures. Lacosamide is part of a larger class of drugs known as Central Nervous System (CNS) drugs. These drugs are used to treat a variety of neurological conditions, including epilepsy, Parkinson's disease, Alzheimer's disease, and multiple sclerosis. CNS drugs are typically prescribed by neurologists and other healthcare professionals. The lacosamide market is highly competitive, with several major pharmaceutical companies offering products. Some of the companies in the market include GlaxoSmithKline, Pfizer, Novartis, Sanofi, and Johnson & Johnson. Show Less Read more